Evidence map›Paper›PMID 30061296›Full record

ArticleAntimicrobial agents and chemotherapy2018

Impact of Inducible

Adriana K Jones, Srijan Ranjitkar, Sara Lopez, Cindy Li, Johanne Blais, Folkert Reck, Charles R Dean

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β-Lactam Antibiotics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  2. Article
  3. Transferable AmpCs inAntimicrobial agents and chemotherapy · 2024
    Article
  4. Article
  5. Article
  6. New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.Translational research : the journal of laboratory and clinical medicine · 2020
    Review
  7. Mode of Action of the Monobactam LYS228 and Mechanisms DecreasingAntimicrobial agents and chemotherapy · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adriana K Jones *Novartis Institutes for BioMedical Research, Emeryville, California, USA.
Srijan Ranjitkar *Novartis Institutes for BioMedical Research, Emeryville, California, USA.
Sara LopezNovartis Institutes for BioMedical Research, Emeryville, California, USA.
Cindy LiNovartis Institutes for BioMedical Research, Emeryville, California, USA.
Johanne BlaisNovartis Institutes for BioMedical Research, Emeryville, California, USA.
Folkert ReckNovartis Institutes for BioMedical Research, Emeryville, California, USA.
Charles R DeanNovartis Institutes for BioMedical Research, Emeryville, California, USA charlesr.dean@novartis.com.ORCID 0000-0001-9858-9818
Novartis (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Twenty-three

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesKlebsiella pneumoniaeMicrobial Sensitivity TestsMutationPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-lactamasesDHA-1KlebsiellaLYS228peptidoglycanplasmid

Identifiers

PMID30061296
PMCPMC6153798
OpenAlexW2887200300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.